We use cookies 🍪
We use cookies and other similar technologies to improve your browsing experience and the functionality of our site. Learn more in our Privacy Policy.

ITA3644

ITA3644
ITA3644
ITA3644
ITA3644
ITA3644
ITA3644
ITA3644
from
$526.00
Price in reward points: 526
  • Catalog: ITA3644
  • Gene/Protein: KLK6
  • Product Description: Immunotag™ KLK6 Antibody

Available Options

Immunotag™ KLK6 Antibody
Antibody Specification
Datasheet

IMPORTANT NOTE This product is custom manufactured with a lead time of 3-4 weeks. Once in production, this item cannot be cancelled from an order and is not eligible for return.
Target Protein KLK6
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IHC,ELISA
Recommended Dilution WB 1:500-1:2000 IHC 1:50-1:200
Concentration 1 mg/ml
Reactive Species Human
Host Species Rabbit
Immunogen A synthesized peptide
Specificity KLK6 antibody detects endogenous levels of total KLK6
Purification The antiserum was purified by peptide affinity chromatography.
Form Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Gene Name KLK6
Accession No. Q92876
Alternate Names Bssp; hK 6; hK6; Kallikrein 6 precursor; Kallikrein related peptidase 6; Kallikrein-6; Kallikrein6; KLK 6; Klk 7; KLK 9; Klk29; Klk6; KLK6_HUMAN; Klk7; KLK9; MGC9355; mGK 1; mGK1; MSP; Neurosin; Protease M; Protease serine 18; Protease serine 9; PRSS 18; PRSS 9; PRSS18; PRSS9; Serine protease 18; Serine protease 9; SP 59; SP59; Tissue kallikrein; TK; Zyme;
Description Serine protease which exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. Degrades alpha-synuclein and prevents its polymerization, indicating that it may be involved in the pathogenesis of Parkinson disease and other synucleinopathies. May be involved in regulation of axon outgrowth following spinal cord injury. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis.
Cell Pathway/ Category Primary Polyclonal Antibody
Protein MW 30 kDa
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
Captcha